Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma

Figure 3 Expression of FABP family members in tumor tissues and non-tumor tissue control in various cancer types. A-B: Expression of each FABP family member (FABP1, FABP2, FABP3, FABP4, FABP5, FABP6, FABP7, PMP2, FABP9 and FABP12) in tumor tissues and non-tumor tissue control in various cancer types (A) and statistical significance when comparing their expression in tumor tissues with non-tumor tissue control (B) using GEPIA2 portal; C: Higher expression of FABP4 and FABP5, but not FABP1, was observed in liver tumor tissues comparing to non-tumor tissue control; D-E: High expression levels of FABP5, but not FABP1 or FABP4, in liver cancer correlate with overall patient survival (D) and disease-free survival (E). ^aP < 0.05.